UG6-44972-64432 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-10-29
Dose 1 — Moderna
2022-10-30
Registered in v-safe
2022-10-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-10-31
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-11-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-11-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-11-03
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-11-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-11-05
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-11-12
Survey response — day 14, dose 1, under 3
MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: Good

Free text: Cold ( coughing, snotty)

MedDRA releases: 2024-11 · check-in free text available
2022-11-19
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-11-26
Dose 2 — Moderna
2022-11-26
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-11-27
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-11-28
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-11-29
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-11-30
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-12-01
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-12-02
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-12-03
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-12-10
Survey response — day 14, dose 2, under 3
MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: Good

Free text: Cold symptoms (runny/stuffy nose)

MedDRA releases: 2024-11 · check-in free text available
2022-12-17
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-24
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-31
Survey response — day 35, dose 2, under 3
MedDRA: Respiratory syncytial virus infection — Feeling: Fair

Free text: RSV

MedDRA releases: 2024-11 · check-in free text available
2023-01-07
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-28
Dose 3 — Moderna
2023-02-27
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-04-29
Survey response — 3 months, dose 3, under 3
MedDRA: Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-10-29	Moderna	No
2	2022-11-26	Moderna	No
3	2023-01-28	Moderna	No

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-11-12

Symptoms: Cold ( coughing, snotty)

Release 12 (Under 3) — day 14, dose 2, under 3

2022-12-10

Symptoms: Cold symptoms (runny/stuffy nose)

Release 12 (Under 3) — day 35, dose 2, under 3

2022-12-31

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release